Last edition
News about "drug delivery technology"
Formosa Pharmaceuticals Partners with Singapore Eye Research Institute for Corneal Disease Therapies
Formosa Pharmaceuticals partners with Singapore Eye Research Institute to develop next-generation ophthalmic formulations using APNT nanoparticle technology and advanced clinical research expertise for corneal diseases.
Drug Delivery Technology | 02/05/2026 | By News Bureau | 106
Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza with ENHANZE
Tecentriq Hybreza can be injected subcutaneously in approximately 7 minutes compared to 30-60 minutes for standard intravenous (IV) infusion of Tecentriq (atezolizumab).
Drug Delivery Technology | 13/09/2024 | By Aishwarya | 536
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy